Urology Times spoke with Raoul S. Concepcion, MD, FACS, and Christopher M. Pieczonka, MD, about advances made in the prostate cancer space in 2020.
EP. 1: PSMA in Prostate Cancer
EP. 2: Metastatic Castrate-Resistant Prostate Cancer
EP. 3: PARP Inhibitors and Immunotherapy in Prostate Cancer
ARCHER trial opens enrollment to assess shorter duration of radiation therapy for MIBC
FDA grants fast track designation to HLD-0915 in mCRPC
What should the adult urologist know about pediatric urologic cancers?
FDA grants de novo authorization to ArteraAI Prostate